NCT05420948 2026-04-09
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
University of Chicago
Phase 2 Suspended
University of Chicago
Hoosier Cancer Research Network
University of Maryland, Baltimore
Northwell Health